14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia)

Diabetic Ketoacidosis & Environmental Emergencies in Pediatric Transport

Pediatric endocrine and environmental crises present some of the most physiologically challenging transport missions. Diabetic ketoacidosis (DKA), submersion injuries, and accidental hypothermia require strict adherence to evidence-based protocols to prevent iatrogenic complications. In DKA, excessive or rapid fluid and insulin administration triggers fatal cerebral edema. In submersion and hypothermia, mechanical trauma or premature pharmacotherapy triggers refractory ventricular arrhythmias. Transport specialists must anticipate these pitfalls and execute precise, disciplined interventions in transit.

---

Pediatric Diabetic Ketoacidosis (DKA): The Biochemical Triad

Diabetic Ketoacidosis represents acute metabolic decompensation secondary to an absolute or profound relative deficiency of circulating insulin, coupled with a compensatory hypersecretion of counter-regulatory hormones (glucagon, epinephrine, cortisol, and growth hormone). DKA is defined by a strict biochemical triad:

1. Hyperglycemia: Serum blood glucose $> 200\text{ mg/dL}$ ($11.1\text{ mmol/L}$).
2. Metabolic Acidosis: Venous pH below 7.30 or serum bicarbonate below 18 mEq/L (ISPAD 2022 raised the bicarbonate threshold from 15).
3. Ketosis: Ketonemia (serum $\beta$-hydroxybutyrate $\ge 3.0\text{ mmol/L}$) or moderate-to-large ketonuria.

Severity Stratification of Pediatric DKA

• Mild DKA: Venous pH 7.20 to 7.29 or serum bicarbonate below 18 mEq/L (ISPAD 2022).
• Moderate DKA: Venous pH 7.10 to 7.19 or serum bicarbonate below 10 mEq/L.
• Severe DKA: Venous $\text{pH} < 7.10$ or serum bicarbonate $< 5\text{ mEq/L}$.

                         PATHOPHYSIOLOGY OF PEDIATRIC DKA
                             Absolute Insulin Deficiency
                       + Counter-Regulatory Hormone Surge
                                     │
        ┌────────────────────────────┴────────────────────────────┐
        ▼                                                         ▼
Increased Glycogenolysis & Gluconeogenesis             Unchecked Adipose Lipolysis
Decreased Peripheral Glucose Uptake                   Excess Free Fatty Acids
        │                                                         │
        ▼                                                         ▼
Hyperglycemia (>200 mg/dL)                            Hepatic Beta-Oxidation
        │                                                         │
        ▼                                                         ▼
Exceeds Renal Threshold (>180 mg/dL)                  Ketoacid Generation
Glucosuria & Osmotic Diuresis                         (Beta-hydroxybutyrate & Acetoacetate)
        │                                                         │
        ▼                                                         ▼
Massive Water & Electrolyte Loss                      High Anion Gap Metabolic Acidosis
Intravascular Hypovolemia (5-10% Dehydration)         Kussmaul Breathing (Blowing off CO2)

In the absence of insulin, peripheral tissues cannot absorb glucose. The liver accelerates glycogenolysis and gluconeogenesis, producing extreme hyperglycemia that exceeds the renal tubular absorptive threshold (~180 mg/dL). Glucosuria causes profound osmotic diuresis, purging massive quantities of free water, sodium, potassium, chloride, and phosphate. Simultaneously, unchecked lipolysis floods the liver with free fatty acids, which undergo mitochondrial beta-oxidation into acidic ketone bodies: $\beta$-hydroxybutyric acid and acetoacetic acid. This generates a severe high-anion-gap metabolic acidosis, triggering deep, rapid sighing respirations (Kussmaul breathing) as the respiratory center hyperventilates to eliminate carbon dioxide.

---

Fluid & Electrolyte Resuscitation: Gradual Correction Principles

Iatrogenic fluid shifts are the single greatest risk factor for DKA-related mortality. Rapid rehydration drives free water into hyperosmolar brain cells, causing cerebral edema.

Core Rules of Transport Fluid Management in DKA

1. Isotonic Initial Resuscitation: ISPAD 2022 recommends starting fluid replacement immediately with 10–20 mL/kg of isotonic crystalloid (0.9% saline or a balanced solution) over 20–30 minutes. In shock, 20 mL/kg is given as quickly as possible and repeated as needed.
2. Slow Deficit Replacement (24 to 48 Hours): Calculate the fluid deficit assuming 5% dehydration in mild DKA or 7% to 10% dehydration in moderate-to-severe DKA. Subtract the initial bolus from this calculated deficit. The remaining deficit PLUS ongoing baseline maintenance fluid must be replaced evenly and slowly over 24 to 48 hours.
3. Rate Guide: After the initial bolus, total fluid rates generally do not need to exceed 1.5 to 2 times the normal maintenance rate. The PECARN FLUID trial (2018) found that faster versus slower rehydration with 0.9% or 0.45% saline did not change rates of clinically apparent brain injury, so shock must never be under-treated for fear of cerebral edema.
4. Never Use Hypotonic Fluids Early: Maintain isotonic IV fluids (0.9% Normal Saline or balanced crystalloid) for at least the initial 4 to 6 hours of resuscitation. Avoid 0.45% NS in early management.

Potassium Dynamics in DKA

Total body potassium is universally depleted through prolonged osmotic diuresis and vomiting (deficits average 3 to 5 mEq/kg). However, initial lab results frequently display normal or elevated serum potassium. This occurs because metabolic acidosis drives intracellular potassium into the extracellular space in exchange for hydrogen ions ($H^+$), and insulin deficiency prevents cellular potassium uptake.

• The Potassium Rule: As soon as insulin therapy begins and rehydration restores intravascular volume, potassium shifts precipitously back into cells. If uncorrected, this causes catastrophic, fatal cardiac arrhythmias.
• Replacement Protocol: Add 20 to 40 mEq/L of potassium (divided as 50% Potassium Chloride and 50% Potassium Phosphate to concurrently replace phosphate and prevent hyperchloremia) to all IV maintenance fluids as soon as urine output is documented and serum potassium drops below 5.5 mEq/L.
• If a patient presents with hypokalemia, ISPAD advises starting potassium replacement with the initial fluids, before insulin. Insulin is deferred until potassium is being replaced and is not critically low, because insulin drives potassium into cells and can trigger arrhythmias.

---

Insulin Therapy & The Transport 'Two-Bag' System

Strict Prohibition of Insulin Boluses

• NEVER administer an IV insulin bolus to a pediatric patient with DKA. IV boluses cause rapid osmotic shifts, precipitous drops in serum osmolality, and severe hypokalemia, and are directly correlated with lethal cerebral edema.
• Timing of Insulin Infusion: Delay insulin infusion until 1 to 2 hours AFTER fluid resuscitation has begun. Re-establishing circulating volume and renal perfusion prior to initiating insulin reduces the risk of rapid osmolar collapse.
• Infusion Dosing: Continuous IV infusion of Regular Insulin at 0.05 to 0.1 unit/kg/hr. The target rate of blood glucose decline is 50 to 100 mg/dL/hr.

The Two-Bag Fluid System: Gold Standard for Transport

Transport environments demand rapid adaptability without the risk of stopping insulin or repeatedly hanging custom fluid mixtures. The two-bag system solves this dilemma elegantly:

• Bag 1 (Zero Dextrose): 0.9% Normal Saline with 20 to 40 mEq/L KCl / K-Phos.
• Bag 2 (High Dextrose): 10% Dextrose in 0.9% Normal Saline with 20 to 40 mEq/L KCl / K-Phos.

                  THE TRANSPORT TWO-BAG SYSTEM IN DKA
  Total Target Hourly Rate = 150 mL/hr (1.5x Maintenance) [Runs Constant]
  Regular Insulin Infusion = 0.05 - 0.1 unit/kg/hr [Runs Constant to Clear Ketoacids]

  Blood Glucose > 300 mg/dL:        Bag 1 (0% Dex) = 150 mL/hr  │ Bag 2 (D10) =   0 mL/hr
  Blood Glucose 250 - 300 mg/dL:    Bag 1 (0% Dex) = 112 mL/hr  │ Bag 2 (D10) =  38 mL/hr (D2.5)
  Blood Glucose 200 - 250 mg/dL:    Bag 1 (0% Dex) =  75 mL/hr  │ Bag 2 (D10) =  75 mL/hr (D5)
  Blood Glucose 150 - 200 mg/dL:    Bag 1 (0% Dex) =  38 mL/hr  │ Bag 2 (D10) = 112 mL/hr (D7.5)
  Blood Glucose < 150 mg/dL:        Bag 1 (0% Dex) =   0 mL/hr  │ Bag 2 (D10) = 150 mL/hr (D10)

• Mechanism: Both bags are connected to the same vascular access line via a Y-connector on separate programmable infusion pumps. The combined rate of Bag 1 plus Bag 2 always equals the total calculated hourly fluid requirement. As blood glucose falls below 250 to 300 mg/dL, the transport clinician shifts fluid delivery from Bag 1 to Bag 2.
• Clinical Purpose: This allows the clinician to maintain serum glucose between 150 and 200 mg/dL while keeping the insulin infusion running at 0.05 to 0.1 unit/kg/hr. Insulin is required to switch off lipolysis, eliminate ketoacidosis, and close the anion gap. Never decrease or turn off the insulin infusion simply because glucose drops; instead, infuse more dextrose via Bag 2!

---

Cerebral Edema in DKA: Early Warning & Emergent Transport Rescue

Cerebral edema is the leading cause of mortality in pediatric DKA, occurring in 0.5% to 1.0% of episodes and accounting for 60% to 90% of all pediatric DKA deaths. It typically manifests 4 to 12 hours after initiating therapy, often during transport.

High-Risk Indicators for Cerebral Edema

• Younger age (<5 years) or new-onset Type 1 Diabetes
• Severe initial acidosis (venous $\text{pH} < 7.10$, bicarbonate $< 5\text{ mEq/L}$)
• Elevated initial Blood Urea Nitrogen (BUN) and marked initial hyperosmolality
• Administration of an IV insulin bolus
• Very large fluid volumes (historically implicated, although the PECARN FLUID trial did not find that faster rehydration increased brain injury)
• Precipitous drop in serum glucose (>100 mg/dL/hr)
• Failure of corrected serum sodium to rise as blood glucose declines ($[\text{Corrected } Na = \text{Measured } Na + 1.6 \times (\text{Glucose} - 100)/100]$)

Clinical Presentation

Early signs include sudden headache, vomiting, progressive lethargy, irritability, or decreased Glasgow Coma Scale (GCS) score. Late signs include Cushing's triad (bradycardia, hypertension, and irregular respirations), pupillary asymmetry, cranial nerve palsies (CN VI abducens palsy), and decerebrate or decorticate posturing.

Emergent Bedside Management Protocol

1. Administer Hyperosmolar Therapy Immediately:
   • 3% Hypertonic Saline: 2.5 to 5 mL/kg IV/IO over 10 to 15 minutes (ISPAD) (preferred by many transport services for sustained osmolar gradient without diuretic volume depletion), OR
   • Mannitol: 0.5 to 1.0 g/kg IV/IO over 10 to 15 minutes.
2. Restrict IV Fluids: Reduce the fluid infusion rate by about one-third.
3. Positioning: Elevate the head of the transport stretcher to 30 degrees in a midline neutral position to facilitate cerebral venous drainage.
4. Airway & Ventilation Pearls: If the patient requires endotracheal intubation for airway protection, avoid aggressive hyperventilation. Hyperventilation ($PaCO_2 < 30\text{ mmHg}$) induces severe cerebral vasoconstriction, worsening focal cerebral ischemia and tissue infarction. Target normocapnia ($PaCO_2\text{ 35 to 40 mmHg}$). Pre-treat intubation with an osmotic agent.

---

Pediatric Drowning & Submersion Injury in Transport

Drowning is a primary respiratory impairment resulting from submersion or immersion in liquid. The fundamental pathology is hypoxemia, not electrolyte imbalance.

                      PATHOPHYSIOLOGY OF SUBMERSION INJURY
                         Submersion & Involuntary Gasp
                                     │
                                     ▼
                       Liquid Aspiration (1-3 mL/kg)
                                     │
             ┌───────────────────────┴───────────────────────┐
             ▼                                               ▼
  Alveolar Surfactant Washout                      Direct Alveolar-Capillary
   & Surfactant Inactivation                         Membrane Disruption
             │                                               │
             ▼                                               ▼
   Massive Micro-Atelectasis                       Non-Cardiogenic Pulmonary Edema
             │                                               │
             └───────────────────────┬───────────────────────┘
                                     ▼
                     Severe V/Q Mismatch & Intrapulmonary Shunt
                                     │
                                     ▼
                      Profound Hypoxemia & Acidosis
                                     │
                                     ▼
                     Secondary Hypoxic-Ischemic Brain Injury

• Surfactant Depletion & Alveolar Washout: Ingestion and aspiration of even small volumes of water (1 to 3 mL/kg) dilutes, washes out, and destroys alveolar surfactant. This results in massive micro-atelectasis, non-cardiogenic pulmonary edema, severe ventilation-perfusion ($V/Q$) mismatch, and large right-to-left intrapulmonary shunting.
• Freshwater vs Saltwater: Both freshwater (hypotonic) and saltwater (hypertonic) produce clinically indistinguishable pulmonary damage: alveolar collapse, pulmonary edema, and acute hypoxemic respiratory failure. Significant systemic electrolyte derangements are exceptionally rare in non-fatal drowning.

Transport Ventilatory Management

• High PEEP / CPAP Therapy: Continuous positive airway pressure (CPAP) or mechanical ventilation with elevated PEEP (8 to 12 cmH2O) is essential to recruit atelectatic alveoli, restore functional residual capacity (FRC), and displace transudated alveolar fluid back into pulmonary capillaries.
• Lung-Protective Ventilation: Deliver tidal volumes of 6 to 8 mL/kg of ideal body weight, keeping inspiratory plateau pressures $< 30\text{ cmH2O}$. Permit mild permissive hypercapnia if needed to prevent barotrauma.
• Decompress the Stomach: Submersion victims swallow large quantities of water and air during panic and resuscitation. A large-bore orogastric or nasogastric tube must be placed immediately to evacuate gastric contents, eliminate diaphragmatic splinting, and prevent massive pulmonary aspiration.
• Medication Restrictions: Routine prophylactic antibiotics and systemic corticosteroids are NOT recommended; they do not improve outcomes and select for resistant pulmonary pathogens.

---

Accidental Hypothermia & Resuscitation Rules

Accidental hypothermia is defined as an involuntary drop in core body temperature below 35°C (95°F). Children are predisposed to rapid hypothermia due to a high body surface area-to-mass ratio, thin subcutaneous fat, and limited glycogen stores.

Staging of Accidental Hypothermia (Swiss System)

• Stage I (Mild, 32°C to 35°C / 90°F to 95°F): Patient is conscious and shivering vigorously. Tachycardia, tachypnea, and peripheral vasoconstriction are present. Cold diuresis occurs.
• Stage II (Moderate, 28°C to 32°C / 82°F to 90°F): Shivering stops. Progressive lethargy, dilated sluggish pupils, hypoventilation, bradycardia, and hypotension develop. Characteristic Osborn (J) waves (a positive deflection at the QRS-ST junction) appear on the ECG.
• Stage III (Severe, 24°C to 28°C / 75°F to 82°F): Coma, unrecordable blood pressure, extreme bradycardia, and pulmonary edema. The myocardium is exquisitely irritable; spontaneous ventricular fibrillation (VF) or asystole may occur.
• Stage IV (Apparent Death, <24°C / <75°F): Asystole or pulseless VF. The patient appears clinically deceased.

The Arrhythmogenic 'Cold Myocardium' & Rough Handling

In moderate-to-severe hypothermia, the myocardium is extraordinarily irritable. Rough handling, sudden movement, jostling the patient during litter transfers, or blind endotracheal suctioning can easily trigger refractory Ventricular Fibrillation. Patients must be moved with extreme gentleness, immobilized smoothly, and packaged carefully during vehicle loading.

Cardiac Arrest Resuscitation Rules in Hypothermia

1. Core Temperature < 30°C (<86°F):
   • Defibrillation Limit: If VF or pulseless VT is detected, deliver up to 3 defibrillation attempts (2 to 4 J/kg). If VF persists after 3 shocks, defer further defibrillation until the patient's core temperature is rewarmed above 30°C.
   • Withhold Resuscitation Drugs: Do not administer IV epinephrine or antiarrhythmics (amiodarone/lidocaine). At core temperatures <30°C, hepatic and renal metabolic clearance is near zero. Repeated doses accumulate in the central circulation, creating lethal toxic drug concentrations that trigger fatal arrhythmias once the patient rewarms.
2. Core Temperature 30°C to 35°C (86°F to 95°F):
   • Double the dosing interval for standard resuscitation medications (e.g., Epinephrine every 6 to 10 minutes instead of every 3 to 5 minutes).
3. Core Temperature Monitoring: Accurate core temperature monitoring requires an esophageal thermistor probe placed in the lower third of the esophagus (reflecting left atrial temperature) in intubated patients. Rectal probes reflect core temperature with significant lag during rapid rewarming.
4. Rewarming Modalities:
   • Passive External: Remove all wet clothing; cover with dry blankets and windproof thermal wraps; maintain transport vehicle cabin temperature at 24°C to 28°C.
   • Active External: Forced-air warming blankets (e.g., Bair Hugger) over the torso. Avoid active warming of extremities first, which causes peripheral vasodilation, profound hypotension, and "core afterdrop" (shunting cold, acidotic blood from the limbs back to the heart).
   • Active Internal: Infuse warmed isotonic IV crystalloids (38°C to 42°C via in-line fluid warmers), deliver warmed humidified oxygen (40°C to 42°C) via ventilator circuit, and in extreme cases initiate extracorporeal life support (ECMO) at the destination center.
5. "Not Dead Until Warm and Dead": No hypothermic pediatric arrest victim should be pronounced deceased until active internal rewarming has restored the core body temperature to ≥32°C to 35°C without return of spontaneous circulation.